Reduced SCFA levels are commonly reported in depression and anxiety models (Li Z. et al., 2022); oral sodium propionate can ameliorate depressive-like behaviors by increasing central histone H3 acetylation levels and activating BDNF expression, among other mechanisms (Behrens et al., 2024). The gene discussed is BDNF; the disease is depressive symptom measurement.